Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil for refractory sarcoidosis
ChiCTR2500100359Phase 4Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in pulmonary sarcoidosis (2 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoint: Sarcoidosis treatment score. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on ChiCTR2500100359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100359.